Ethos Technologies Corp.(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LIFE Ethos Technologies Corp.

盘前交易 03-02 06:14:16 EST

12.35

+0.07

+0.57%

最高12.60	最低11.50	成交量47.48万
今开12.22	昨收12.28	日振幅8.96%
总市值7.73亿	流通市值1.30亿	总股本6,256万
成交额577.79万	换手率4.52%	流通股本1,050万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LIFE","market":"US","secType":"STK","nameCN":"Ethos Technologies Corp.","latestPrice":12.35,"timestamp":1772226000000,"preClose":12.28,"halted":0,"volume":474796,"delay":0,"changeRate":0.005700325732899046,"floatShares":10500000,"shares":62558380,"eps":1.137,"marketStatus":"盘前交易","change":0.07,"latestTime":"03-02 06:14:16 EST","open":12.22,"high":12.6,"low":11.5,"amount":5777941.135148,"amplitude":0.089577,"askPrice":14.11,"askSize":100,"bidPrice":11.5,"bidSize":400,"shortable":3,"etf":0,"ttmEps":1.137,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772461800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1769662800000,"exchange":"NASDAQ","adjPreClose":12.35,"postHourTrading":{"tag":"盘后","latestPrice":12.11,"preClose":12.35,"latestTime":"19:50 EST","volume":1214,"amount":14918.75,"timestamp":1772239813049,"change":-0.24,"changeRate":-0.019433,"amplitude":0.019433},"volumeRatio":1.1009731800428233,"impliedVol":1.3845,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/LIFE","defaultTab":"news","newsList":[{"id":"1173445936","title":"美国银行全球研究首次覆盖Ethos Technologies，给予买入评级，目标价15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173445936","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173445936?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:45","pubTimestamp":1771847112,"startTime":"0","endTime":"0","summary":"美国银行全球研究（Bofa Global Research）近日宣布，对Ethos Technologies Inc.（股票代码：LIFE）启动覆盖研究，并首次给予“买入”评级。报告同时设定了该公司股票的目标价格为15美元。\n这一评级反映了机构对Ethos Technologies未来增长潜力和市场前景的积极展望。分析指出，公司在其技术领域具备竞争优势，目标价的设定也体现了对其股价上行空间的预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4173","LIFE"],"gpt_icon":0},{"id":"1191941971","title":"巴克莱首予Ethos Technologies增持评级 目标价20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191941971","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191941971?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:33","pubTimestamp":1771846417,"startTime":"0","endTime":"0","summary":"巴克莱银行近日宣布，首次将Ethos Technologies Corp.纳入研究覆盖范围，并给予\"增持\"评级，同时设定目标股价为20美元。这一举措显示该投行对Ethos Technologies未来增长前景持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","LIFE","BK4139","BK4563"],"gpt_icon":0},{"id":"1116779730","title":"Cannabix Technologies宣布非经纪LIFE私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1116779730","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116779730?lang=zh_cn&edition=full","pubTime":"2026-02-07 08:01","pubTimestamp":1770422489,"startTime":"0","endTime":"0","summary":"本信息不面向美国新闻通讯社发布或在美利坚合众国境内传播。Cannabix Technologies Inc.欣然宣布，其计划完成一项非经纪私募配售。在此情况下，权证将于公司发布触发事件通知之日起30个日历日后到期。公司部分内部人士可能参与本次发行的单位认购。Cannabix计划将本次融资的净收益用于制造库存和劳动力支出、一般行政费用以及未分配的营运资金。根据该豁免，本次发行所发股份不受加拿大适用证券法转售限制约束。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","LIFE","BK4139"],"gpt_icon":0},{"id":"2607766387","title":"在线人寿保险服务商Ethos(LIFE.US)今晚登陆纳斯达克：IPO定价19美元，募资约2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607766387","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607766387?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:15","pubTimestamp":1769656539,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，在线人寿保险服务商Ethos Technologies已将其美国首次公开募股定价为每股 19 美元。据悉，公司在此次 IPO 中共发行了 1050 万股普通股，其中约一半由公司新发，另一半则由现有股东转让，总计募集资金至多 2.105 亿美元。Ethos 表示，其平台与承保引擎改变了人寿保险的购买、销售与风险管理方式，帮助客户在数分钟内获得保障。Ethos 计划于 2026 年 1 月 29 日(周四)正式登陆纳斯达克交易所，股票代码定为 “LIFE”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"在线人寿保险服务商Ethos(LIFE.US)今晚登陆纳斯达克：IPO定价19美元，募资约2亿美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1147","QYLD","TSYW.SI","GPIQ","QLD","BK4563","TQQQ","PSQ","LIFE","QQQJ","QYLG","SQQQ","USAW.SI","NVIW.SI","BK4139","BK4007","QQQE","JEPQ","QQQY","QQQM","QID","USJW.SI","MNQmain"],"gpt_icon":1},{"id":"2605758331","title":"在线人寿保险交易平台Ethos(LIFE.US)IPO定价18-20美元/股 拟筹资2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605758331","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605758331?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:49","pubTimestamp":1768978147,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在线人寿保险交易及分析平台服务商Ethos Technologies周二公布了其首次公开募股条款。该公司计划以每股18至20美元的价格发行1050万股股票，以筹资2亿美元。该公司计划在纳斯达克交易所上市，股票代码为“LIFE”。Ethos成立于2016年，总部位于美国加利福尼亚州旧金山。截至2025年9月30日，该平台已激活48万份保单。数据显示，该公司在截至2025年9月30日的12个月营收为3.44亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"在线人寿保险交易平台Ethos(LIFE.US)IPO定价18-20美元/股 拟筹资2亿美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LIFE","BK4139","BK4563"],"gpt_icon":0},{"id":"2439869503","title":"Atyr Pharma, Inc.盘中异动 快速下跌5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439869503","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439869503?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:01","pubTimestamp":1717002103,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时01分，Atyr Pharma, Inc.股票出现异动，股价大幅下挫5.03%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。该信息摘要如下：AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010144968108ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010144968108ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE","BK4563","BK4139"],"gpt_icon":0},{"id":"2439528379","title":"AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439528379","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439528379?lang=zh_cn&edition=full","pubTime":"2024-05-29 19:36","pubTimestamp":1716982576,"startTime":"0","endTime":"0","summary":"AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291936199574b304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291936199574b304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE"],"gpt_icon":0},{"id":"2438098768","title":"AtyR Pharma根据纳斯达克上市规则5635 (C) (4) 宣布激励补助金","url":"https://stock-news.laohu8.com/highlight/detail?id=2438098768","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438098768?lang=zh_cn&edition=full","pubTime":"2024-05-25 04:05","pubTimestamp":1716581123,"startTime":"0","endTime":"0","summary":"AtyR Pharma根据纳斯达克上市规则5635 (C) (4) 宣布激励补助金","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525040526955ab804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525040526955ab804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":[".IXIC","BK4563","BK4504","PSQ","MNQmain","LU0098860793.USD","BK4139","LU1162221912.USD","BK4534","LU0052756011.USD","BK4566","LU1267930227.SGD","BK4207","QQQ","NQmain","BK4007","SQQQ","TQQQ","LIFE","LU0310800965.SGD","QLD","IE00BSNM7G36.USD","LU0980610538.SGD","LU0130102774.USD","LU0648001328.SGD","BK4585","NDX","QID","LU1201861249.SGD","ARTL","LU0128525689.USD","LU0320765646.SGD","BK4588"],"gpt_icon":0},{"id":"2435541320","title":"Atyr Pharma, Inc.盘中异动 下午盘大幅上涨5.00%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435541320","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435541320?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:37","pubTimestamp":1715708252,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时37分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Humacyte Inc C/Wts 27/08/2026 、Prokidney Corp.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为159.87%、60.37%、33.58%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为69.43%、65.81%、53.25%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150137337927a2d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150137337927a2d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","LIFE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ethos.com","stockEarnings":[{"period":"1week","weight":0.1435},{"period":"1month","weight":-0.35},{"period":"ytd","weight":-0.35}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ethos Technologies Inc.于2016年7月根据特拉华州法律注册成立。Ethos Technologies是一家致力于变革人寿保险行业的科技公司。该公司构建了一个垂直整合的技术平台，使每个人都能便捷、经济地获得人寿保险。该平台简化了从分销到承保、激活和管理的整个保险价值链。通过其三方技术平台，他们服务于日益壮大的消费者、代理商和保险公司生态系统。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.6,"avgChangeRate":-0.014529},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024172},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.082422},{"month":9,"riseRate":0.555556,"avgChangeRate":0.120154},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.07207},{"month":11,"riseRate":0.555556,"avgChangeRate":0.026072},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.077972}],"exchange":"NASDAQ","name":"Ethos Technologies Corp.","nameEN":"Ethos Technologies Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ethos Technologies Corp.(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ethos Technologies Corp.(LIFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ethos Technologies Corp.,LIFE,Ethos Technologies Corp.股票,Ethos Technologies Corp.股票老虎,Ethos Technologies Corp.股票老虎国际,Ethos Technologies Corp.行情,Ethos Technologies Corp.股票行情,Ethos Technologies Corp.股价,Ethos Technologies Corp.股市,Ethos Technologies Corp.股票价格,Ethos Technologies Corp.股票交易,Ethos Technologies Corp.股票购买,Ethos Technologies Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ethos Technologies Corp.(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ethos Technologies Corp.(LIFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}